David Domzalski
2021
In 2021, David Domzalski earned a total compensation of $4.9M as President and Chief Executive Officer at VYNE Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Bonus | $242,910 |
|---|---|
| Option Awards | $2,141,994 |
| Salary | $637,560 |
| Stock Awards | $1,818,861 |
| Other | $11,600 |
| Total | $4,852,925 |
Domzalski received $2.1M in option awards, accounting for 44% of the total pay in 2021.
Domzalski also received $242.9K in bonus, $637.6K in salary, $1.8M in stock awards and $11.6K in other compensation.
Rankings
In 2021, David Domzalski's compensation ranked 2,718th out of 12,405 executives tracked by ExecPay. In other words, Domzalski earned more than 78.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,718 out of 12,405 | 78th |
Division Manufacturing | 1,073 out of 5,494 | 81st |
Major group Chemicals And Allied Products | 421 out of 2,369 | 82nd |
Industry group Drugs | 367 out of 2,090 | 82nd |
Industry Pharmaceutical Preparations | 243 out of 1,537 | 84th |
Source: SEC filing on June 17, 2022.
Domzalski's colleagues
We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2021.